BioSpace News Archive

Jim Gemmell, Ph.D. of computer science, has been appointed chief technology officer of Aural Analytics, Inc., a privately-held digital health company focused on building the world’s most advanced, speech analytics platform based on 25 years of clinical research.

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that updated results and new translational research data from two phase 1 studies evaluating investigational antibody drug conjugates (ADCs) U3-1402 and DS-1062 in patients with advanced or metastatic non-small cell lung cancer (NSCLC) will be presented at the 2019 IASLC World Conference on Lung Cancer (#WCLC19), to be held September 7-10, 2019 in Barcelona, Spain.

Company Well-Positioned to Extend Its Industry Leadership

CureDuchenne announced it has tapped Erin Frey as Senior Director of Advocacy.

Bio-Rad Laboratories, Inc. announced that Fitch Ratings has upgraded Bio-Rad Laboratories, Inc.'s Long-Term Issuer-Default to “BBB” from “BBB-.” The upgrade reflects Bio-Rad’s improved EBITDA and FCF margins, which, according to Fitch Ratings, are trending toward industry averages as a result of cost rationalization initiatives and improvement of internal controls.